Arrowstreet Capital, Limited Partnership Alkermes Plc. Transaction History
Arrowstreet Capital, Limited Partnership
- $148 Billion
- Q3 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Alkermes Plc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,208,944 shares of ALKS stock, worth $35.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,208,944
Previous 103,278
1070.57%
Holding current value
$35.1 Million
Previous $2.95 Million
1127.76%
% of portfolio
0.02%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ALKS
# of Institutions
401Shares Held
176MCall Options Held
901KPut Options Held
400K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$297 Million0.03% of portfolio
-
State Street Corp Boston, MA8.54MShares$248 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY8.09MShares$235 Million1.98% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...